Facilitated By

San Antonio Medical Foundation

News

  • MonarchE Update Benefit of Abemaciclib Increases Over Time - The ASCO Post

    ... the data at the 2022 San Antonio Breast Cancer Symposium (Abstract GS1-09). ... Eisai, AstraZeneca, Roche, Eli Lilly, and Puma Biotechnology.

  • When loved ones become strangers | TPR - Texas Public Radio

    Bioscience-Medicine RelationshipsTop Stories ... San Antonio soccer fans join the Men's World Cup's global audience. Stay Connected.

  • Cemiplimab Plus REGN3767 and Chemo Shows Promise for HER2- Breast Cancer

    ... hormone receptor (HR)-positive, HER2-negative breast cancer, according to research presented at the San Antonio Breast Cancer Symposium 2022.

  • Elacestrant vs Endocrine Monotherapy in Advanced Breast Cancer: Phase III EMERALD Trial

    ... colleagues at the 2022 San Antonio Breast Cancer Symposium (Abstract GS3-01). ... Gilead Sciences, Novartis, Pfizer, and Puma Biotechnology.

  • Texas Children's Hospital announces plan to tackle mental health crisis | TPR

    San Antonio soccer fans join the Men's World Cup's global audience · Union members and allies stand in support of Starbucks workers at a rally at ...